BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4344694)

  • 1. Studies on the functional specificity of cortisone reductase.
    Gibb W; Jeffery J
    Biochem J; 1972 Jul; 128(4):136P. PubMed ID: 4344694
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of the non-steroid adamantanone by crystalline preparations of cortisone reductase.
    Gibb W; Jeffery J
    Biochem J; 1972 Jan; 126(2):443. PubMed ID: 5071180
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relations for the nicotinamide-adenine dinucleotide-linked 20beta-hydroxysteroid oxidoreductase activity of cortisone reductase with special reference to ring B.
    White IH; Jeffrey J
    Biochem J; 1972 Sep; 129(2):24P. PubMed ID: 4345272
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relations for the nicotinamide-adenine-dinucleotide-linked 3-hydroxysteroid oxidoreductase activity of cortisone reductase with special reference to the ring A-B junction and ring D.
    Gibb W; Jeffrey J
    Biochem J; 1972 Sep; 129(2):24P. PubMed ID: 4345271
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the active centre for the 3-hydroxy steroid-nicotinamide-adenine dinucleotide oxidoreductase activity of cortisone reductase.
    Gibb W; Jeffery J
    Biochem J; 1972 Jul; 128(4):136P-137P. PubMed ID: 4344695
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of a 17 beta-sulphate group on reduction of a steroid 3-oxo group by cortisone reductase.
    Gibb W; Jeffery J
    Biochem J; 1972 Nov; 130(1):37P. PubMed ID: 4347792
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural features of ring A and the interaction of 20-oxosteroids with cortisone reductase.
    White IH; Jeffery J
    Eur J Biochem; 1972 Feb; 25(3):409-14. PubMed ID: 4339641
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECT OF THYROXINE ADMINISTRATION ON THE 11-BETA-HYDROXYSTEROID DEHYDROGENASES IN RAT LIVER AND KIDNEY.
    KOERNER DR; HELLMAN L
    Endocrinology; 1964 Oct; 75():592-601. PubMed ID: 14211904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specificity of 3 alpha, 20 beta-hydroxysteroid: nad+ -oxidoreductase (author's transl)].
    Allner R; Eggstein M
    J Clin Chem Clin Biochem; 1976 Feb; 14(2):59-64. PubMed ID: 175129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson A; Wallace AM; Andrew R; Nunez BS; Walker BR; Fraser R; White PC; Connell JM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3570-4. PubMed ID: 10522997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
    Stewart PM; Murry BA; Mason JI
    J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function of cortisone reductase with 20-oxo steroid substrates differing in ring A.
    White IH; Jeffery J
    Biochem J; 1972 Feb; 126(3):10P. PubMed ID: 5075234
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
    Nordenström A; Marcus C; Axelson M; Wedell A; Ritzén EM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1210-3. PubMed ID: 10199755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major influence of a 1 alpha, 2 alpha-methylene group on reduction of a steroid 3-oxo group by 2 nicotinamide-adenine dinucleotide-linked 3-hydroxy steroid oxidoreductases.
    Gibb W; Jeffery J
    Biochem J; 1972 Nov; 130(1):37P-38P. PubMed ID: 4347793
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.
    Stewart PM; Murry BA; Mason JI
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1529-32. PubMed ID: 8200959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?
    Möbus E; Hermans JJ; Maser E
    Endocrine; 1999 Dec; 11(3):301-7. PubMed ID: 10786827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of ring C of 20-oxo steroids and the interaction with cortisone reductase.
    White IH; Jeffery J
    Biochem J; 1974 Feb; 137(2):349-54. PubMed ID: 4824215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy steroid dehydrogenase activities of cortisone reductase.
    Gibb W; Jeffery J
    Biochem J; 1973 Dec; 135(4):881-8. PubMed ID: 4778283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue-specific changes in cortisol metabolism and their potential role in the metabolic syndrome].
    Kerstens MN; Wolffenbuttel BH; Dullaart RP
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):871-6. PubMed ID: 15868991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.